San Francisco
Meridan ReportSan Francisco: Global epicenter of AI and VC

Advertisement · Why this ad?

Health

The excitement around Moderna’s cancer vaccine is cooling. Here’s why.

Marcus Chen
Managing Editor · Monday, October 26, 2026 at 1:50 PM · 1 min read
The excitement around Moderna’s cancer vaccine is cooling. Here’s why. — MarketWatch, San Francisco Health news
Image: MarketWatch

Investors had “incredibly high” expectations around the Phase 3 data for the drugmaker’s experimental cancer treatment.

Up next‘She’s living the dream’: My stepmother said I can buy my childhood home for $850,000. Is she taking advantage of me?Business · 1 min read
You're offline — showing the last loaded page